Citigroup’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-260
Closed -$1K 6191
2022
Q2
$1K Sell
260
-837
-76% -$4.27K ﹤0.01% 6068
2022
Q1
$7K Buy
+1,097
New +$6.77K ﹤0.01% 5695
2021
Q4
Sell
-250
Closed -$2K 6022
2021
Q3
$2K Sell
250
-80
-24% -$820 ﹤0.01% 5670
2021
Q2
$4K Hold
330
﹤0.01% 5877
2021
Q1
$5K Hold
330
﹤0.01% 5898
2020
Q4
$2K Hold
330
﹤0.01% 7245
2020
Q3
$1K Sell
330
-6,822
-95% -$35.5K ﹤0.01% 7374
2020
Q2
$44K Buy
7,152
+6,822
+2,067% +$45.9K ﹤0.01% 6100
2020
Q1
$3K Sell
330
-1,258
-79% -$11.4K ﹤0.01% 7378
2019
Q4
$16K Buy
1,588
+748
+89% +$8.83K ﹤0.01% 7025
2019
Q3
$12K Buy
840
+510
+155% +$10.7K ﹤0.01% 6992
2019
Q2
$9K Buy
+330
New +$9.16K ﹤0.01% 7340

Other funds holding OGI

Citigroup's OGI Position: Q3 2022 in Review

Citigroup sold out of Organigram Holdings (OGI) in Q3 2022, closing a stake of 260 shares — an estimated $1K sold.

Citigroup first reported a position in OGI in Q2 2019 and held it in 12 quarters. The position peaked at $44K in Q2 2020. 120 funds tracked by Wall St. Rank hold OGI as of Q3 2022.

  • Citigroup reported no remaining Organigram Holdings position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 260 Organigram Holdings shares in Q3 2022, an estimated $1K.
  • Citigroup first reported a position in Organigram Holdings in Q2 2019 and held it in 12 quarters.
  • Citigroup's Organigram Holdings position peaked at $44K in Q2 2020.
  • 120 funds tracked by Wall St. Rank held Organigram Holdings as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.